ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Catastrophic Antiphospholipid Syndrome with Pulmonary Hemorrhage: A Case Report

Joy-Ann Tabanor, MD, Hyun Bae, MD, Girish Sonpal, MD, & Karlene Williams, MD  |  August 17, 2015

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by hypercoagulability often manifested as recurrent thrombosis or pregnancy complications, with persistently circulating antiphospholipid (aPL) antibodies or lupus anticoagulant. Catastrophic APS (CAPS), also known as Asherson syndrome, occurs in less than 1% of cases of APS and involves occlusive microangiopathy in at least three organ systems.1 Case…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Antiphospholipid Antibody Syndrome (APS)catastrophic antiphospholipid syndromeClinicalDiagnosishemorrhageHughes Syndromeoutcomepatient carePulmonary

Can Systemic Inflammation Influence Mood?

Simon M. Helfgott, MD  |  August 17, 2015

The Friday night press release: When a politician or any public figure needs to disclose unfavorable news, chances are they will release it sometime on a late Friday afternoon or evening, hoping that nobody is paying attention. In fact, this behavior was coined “the take out the trash day” on the television political drama, The…

Filed under:ConditionsOpinionOther Rheumatic ConditionsPractice SupportRheuminationsSpeak Out Rheum Tagged with:disorderdrug therapyMental Healthpatient carePsychosisrheumatologistSteroidsystemic inflammation

The ACR’s Lupus Initiative Expands Training, Educational Resources

E. William St.Clair, MD  |  August 17, 2015

The Lupus Initiative (TLI) has been an emergent creation inside the American College of Rheumatology (ACR) for the past six years. In 2009, the Office of Minority Health and Office of Women’s Health (now called the Office of Health Disparities) solicited an application from the ACR to develop resources for educating non-rheumatologists, both in training…

Filed under:ConditionsEducation & TrainingPresident's PerspectiveSystemic Lupus Erythematosus Tagged with:AC&REducationLupus InitiativeresourcerheumatologistSLETraining

7 Tips for New Rheumatology Fellows

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  August 17, 2015

About a year ago, I stuffed all my earthly belongings into my black Volkswagen Jetta and set out on a 10-hour interstate journey. I had just graduated from residency at the University of Kentucky and was headed westward, to Iowa City, for a fresh start as a rheumatology fellow. During the 10 hours I spent…

Filed under:Career DevelopmentFrom the CollegeProfessional Topics Tagged with:Careerfellowmedicalpatient careresidencyrheumatologyTraining

Intensive Program Relieves Symptoms of Juvenile Fibromyalgia

Lara C. Pullen, PhD  |  August 17, 2015

Pain can be reduced and functionality significantly improved for children with fibromyalgia without drug therapy, according to a study of 64 children in Philadelphia. Researchers combined intensive physical therapy and psychotherapy in individualized programs to treat the fibromyalgia patients…

Filed under:ConditionsPain SyndromesSoft Tissue Pain Tagged with:FibromyalgiaPainPain Management

Rude Comments Damage Medical Team Performance

Anne Harding  |  August 12, 2015

NEW YORK (Reuters Health)—Medical practitioners’ performance suffers when they are exposed to rudeness, new findings show. Neonatal intensive care unit (NICU) team members who heard disparaging comments while participating in a simulation exercise had lower diagnostic and procedural performance scores compared to team members who didn’t hear rude comments, Dr. Arieh Riskin, of Bnai-Zion Medical…

Filed under:Practice SupportWorkforce Tagged with:Association of Rheumatology Professionals (ARP)behaviornurse

FDA Investigates MRI Safety after Studies Find GBCA Deposits in Brain

Michele B. Kaufman, PharmD, BCGP  |  August 12, 2015

The FDA is investigating the safety of MRIs using gadolinium-based contrast agents, which recent studies have shown may leave deposits of those chemicals in patients’ brain tissue after multiple scans…

Filed under:Drug Updates Tagged with:brainFDAMagnetic resonance imaging (MRI)

China Gets Tougher for Western Drugmakers

Ben Hirschler  |  August 8, 2015

LONDON (Reuters)—The Chinese market is getting tougher for Western pharmaceutical companies as Beijing bears down on a rising healthcare bill and prices come under pressure. The country, which has overtaken Japan as the world’s second largest market for prescription medicines after the U.S., has drawn major investment from global drugmakers in recent years — but…

Filed under:Drug Updates Tagged with:ChinaDrug promotion

Psoriatic Disease Linked to Higher Risk of Uveitis & Vice Versa

Rob Goodier  |  August 7, 2015

NEW YORK (Reuters Health)—Two classes of inflammatory diseases, uveitis and psoriatic disease, appear linked, as a diagnosis of one increases the risk of developing the other, new research has found. A study of Danish patient registries found nearly triple the rate of uveitis among patients with psoriatic arthritis compared to the general population, and double…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:comorbiditiespsoriatic arthritisUveitis

37,000 U.S. Infection-Related Deaths Preventable Over 5 Years

Ransdell Pierson  |  August 5, 2015

(Reuters)—Closer coordination between healthcare facilities and public health departments could save 37,000 U.S. lives over five years by preventing infections from antibiotic-resistant germs and from Clostridium difficile, according to a government report released on Tuesday. Germs that no longer respond to antibiotics cause more than 2 million illnesses and 23,000 deaths each year in the…

Filed under:FacilityPractice Support Tagged with:CDCinfectious diseasemortalitySkilled nursing facility

  • « Previous Page
  • 1
  • …
  • 241
  • 242
  • 243
  • 244
  • 245
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences